Planned Parenthood Minnesota, North Dakota, South Dakota
Planned Parenthood Minnesota, North Dakota, South Dakota was paid $38.35M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 28% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD MINNESOTA, NORTH DAKOTA, SOUTH DAKOTA
SAINT PAUL, MN 55114
SAINT PAUL, MN 55114
33aNPI1629057146assigned 01/12/2006
33bProvider typeSpecialist
28Total paid$38.35M
24GClaims737,782
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Minnesota
Rank by total paid#1 of 41
Median peer was paid$27K
This provider vs. median1,434×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 141,660 | $6.13M | |
| 2019 | 123,626 | $8.17M | |
| 2020 | 120,694 | $7.53M | |
| 2021 | 132,942 | $7.69M | |
| 2022 | 95,628 | $4.34M | |
| 2023 | 81,026 | $2.94M | |
| 2024incomplete | 42,206 | $1.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S4993 | Contraceptive pills for birth control | 28% | 111,396 | 79,537 | $10.81M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 11% | 3,938 | 3,891 | $4.13M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.0% | 39,799 | 38,393 | $2.28M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 25,232 | 24,353 | $2.13M |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 5.2% | 21,839 | 21,380 | $2.01M |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 3.9% | 22,836 | 20,576 | $1.50M |
| J7304 | Contraceptive supply, hormone containing patch, each | 3.9% | 4,060 | 3,841 | $1.48M |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 3.7% | 4,628 | 4,268 | $1.44M |
| 87806 | 3.7% | 49,598 | 48,393 | $1.40M | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.2% | 40,538 | 36,998 | $1.24M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.2% | 40,532 | 36,989 | $1.24M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.8% | 19,785 | 19,321 | $1.08M |
48 more codes
| A4267 | Contraceptive supply, condom, male, each | 2.5% | 82,554 | $947K |
| J7300 | Intrauterine copper contraceptive (paragard) | 1.9% | 696 | $714K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | 1.6% | 767 | $602K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1.2% | 458 | $478K |
| J3490 | Unclassified drugs | 1.1% | 5,365 | $435K |
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 4,674 | $402K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 3,042 | $391K |
| 81025 | <1% | 47,610 | $356K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 25,926 | $341K |
| 11981 | <1% | 3,051 | $314K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,105 | $305K |
| 11982 | <1% | 2,567 | $279K | |
| 86780 | <1% | 20,573 | $257K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,452 | $256K |
| 58300 | <1% | 3,456 | $255K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 6,117 | $177K |
| 58301 | <1% | 1,999 | $163K | |
| 87210 | <1% | 28,371 | $142K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 146 | $113K |
| 36415 | Collection of venous blood by venipuncture | <1% | 38,652 | $113K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,393 | $92K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 4,189 | $82K |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | <1% | 290 | $72K |
| 36416 | <1% | 22,082 | $64K | |
| 99385 | <1% | 419 | $58K | |
| 86592 | <1% | 13,619 | $47K | |
| 83986 | <1% | 11,020 | $37K | |
| 11983 | <1% | 193 | $23K | |
| 86803 | <1% | 1,432 | $19K | |
| 99201 | <1% | 612 | $19K | |
| 88142 | <1% | 1,089 | $18K | |
| 81002 | <1% | 6,050 | $14K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 88 | $12K |
| 87529 | <1% | 117 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 329 | $4K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 104 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 16 | $3K |
| 84403 | <1% | 79 | $2K | |
| 0004A | <1% | 52 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 19 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 68 | $922.06 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,510 | $695.20 |
| 87563 | <1% | 14 | $485.85 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 30 | $453.85 |
| 85018 | <1% | 152 | $353.26 | |
| 87255 | 0% | 28 | $0.00 | |
| S0191 | Misoprostol, oral, 200 mcg | 0% | 13 | $0.00 |
| S0190 | Mifepristone, oral, 200 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTINSON, NICOLE (DIRECTOR, REVENUE MANAGEMENT)
| Provider | Location | Paid |
|---|---|---|
| Planned Parenthood of the Heartland, INC | Iowa City, IA | $2.92M |
| Planned Parenthood Minnesota, North Dakota, South Dakota | Saint Paul, MN | $2.56M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.